NDC 70710-1643
Verapamil Hydrochloride 2.5 mg per 1 mL injection, solution
On the label: Zydus Pharmaceuticals (USA) Inc..
Where it's made
| Factory | Where | Role | Last FDA inspection |
|---|---|---|---|
| Zydus Lifesciences Limited | Vadodara, India | Makes it and tests it | Serious problems, FDA actionApr 23, 2024 · 2 inspections, 1 with FDA action |
Recalls
- Jul 2, 2024 · Class III · Zydus Pharmaceuticals (USA) Inc
Cross contamination with other products.
Lots: Lot# (a) Lots L300255, L300262, Exp Date 07/31/2025; (b)L300263, Exp Date 08/31/2025 - Jul 2, 2024 · Class III · Zydus Pharmaceuticals (USA) Inc
Cross contamination with other products.
Lots: Lot L300269, Exp Date 07/31/2025
Class I recalls are the most serious; Class III the least. A recall covers specific lots, listed on each recall.
Product details
- Generic drug
- Verapamil: every company that makes it
- Form
- injection, solution, intravenous
- Strength
- 2.5 mg per 1 mL
- Approval
- ANDA ANDA214215
- On the market since
- Oct 22, 2020
- Package NDCs
70710-1643-570710-1643-7- Official label
- DailyMed (National Library of Medicine), updated Dec 6, 2024
Got it by mail or from a pharmacy you don't know? Look the pharmacy up on Who Filled My Rx?